133 related articles for article (PubMed ID: 3705062)
1. Apolipoprotein E phenotypes and plasma lipids in young and middle-aged subjects.
Eto M; Watanabe K; Iwashima Y; Morikawa A; Oshima E; Sekiguchi M; Ishii K
Tohoku J Exp Med; 1986 Jan; 148(1):25-34. PubMed ID: 3705062
[TBL] [Abstract][Full Text] [Related]
2. Reciprocal effects of apolipoprotein E alleles (epsilon 2 and epsilon 4) on plasma lipid levels in normolipidemic subjects.
Eto M; Watanabe K; Ishii K
Clin Genet; 1986 Jun; 29(6):477-84. PubMed ID: 3461894
[TBL] [Abstract][Full Text] [Related]
3. Effect of apolipoprotein E3/4 phenotype on postprandial triglycerides and retinyl palmitate metabolism in plasma from hyperlipidemic subjects in Japan.
Kobayashi J; Saito Y; Taira K; Hikita M; Takahashi K; Bujo H; Morisaki N; Saito Y
Atherosclerosis; 2001 Feb; 154(3):539-46. PubMed ID: 11257254
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E2, renal failure and lipid abnormalities in non-insulin-dependent diabetes mellitus.
Horita K; Eto M; Makino I
Atherosclerosis; 1994 Jun; 107(2):203-11. PubMed ID: 7980694
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E phenotype associations with plasma lipoproteins and bone mass in postmenopausal women.
Sanada M; Nakagawa H; Kodama I; Sakasita T; Ohama K
Climacteric; 1998 Sep; 1(3):188-95. PubMed ID: 11907943
[TBL] [Abstract][Full Text] [Related]
6. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism.
St-Amand J; Moorjanit S; Lupien PJ; Prud'homme D; Després JP
Metabolism; 1996 Feb; 45(2):261-7. PubMed ID: 8596500
[TBL] [Abstract][Full Text] [Related]
7. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
Tremblay AJ; Bergeron J; Gagné JM; Gagné C; Couture P
Metabolism; 2005 Aug; 54(8):1014-9. PubMed ID: 16092050
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins.
Gómez-Coronado D; Alvarez JJ; Entrala A; Olmos JM; Herrera E; Lasunción MA
Atherosclerosis; 1999 Nov; 147(1):167-76. PubMed ID: 10525138
[TBL] [Abstract][Full Text] [Related]
9. Distribution of apolipoprotein E between apo B- and non apo B-containing lipoproteins according to apo E phenotype.
Luc G; Ducimetiere P; Bard JM; Arveiler D; Evans A; Cambien F; Fruchart JC; Fievet C
Atherosclerosis; 1997 Jun; 131(2):257-62. PubMed ID: 9199280
[TBL] [Abstract][Full Text] [Related]
10. Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3.
Kobayashi T; Homma Y
J Clin Pharmacol; 2001 Oct; 41(10):1055-8. PubMed ID: 11583472
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
Parhofer KG; Richter WO; Schwandt P
Horm Metab Res; 1990 Nov; 22(11):589-94. PubMed ID: 2272605
[TBL] [Abstract][Full Text] [Related]
12. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
Kobori S; Nakamura N; Uzawa H; Shichiri M
Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
[TBL] [Abstract][Full Text] [Related]
13. Frequency and role of apo E phenotype in familial hypercholesterolemia and non-familial hyperlipidemia in the Japanese.
Kitahara M; Shinomiya M; Shirai K; Saito Y; Yoshida S
Atherosclerosis; 1990 Jun; 82(3):197-204. PubMed ID: 2375785
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein E polymorphism and the distribution profile of very low density lipoproteins; an influence of the E4 allele on large (Sf > 60) particles.
Bioletto S; Fontana P; Darioli R; James RW
Atherosclerosis; 1998 May; 138(1):207-15. PubMed ID: 9678786
[TBL] [Abstract][Full Text] [Related]
15. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E.
Weintraub MS; Eisenberg S; Breslow JL
J Clin Invest; 1987 Dec; 80(6):1571-7. PubMed ID: 3479440
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E polymorphism and hyperlipoproteinemia in obesity.
Eto M; Watanabe K; Ishii K
Int J Obes; 1989; 13(4):433-40. PubMed ID: 2793298
[TBL] [Abstract][Full Text] [Related]
17. A phenocopy of type III dysbetalipoproteinemia occurring in a candidate family for a putative apo E receptor defect.
Davignon J; Dallongeville J; Roederer G; Roy M; Fruchart JC; Kessling AM; Bouthillier D; Lussier-Cacan S
Ann Med; 1991 Apr; 23(2):161-7. PubMed ID: 1648930
[TBL] [Abstract][Full Text] [Related]
18. Effects of probucol on plasma lipids and lipoproteins in familial hypercholesterolemic patients with and without apolipoprotein E4.
Eto M; Sato T; Watanabe K; Iwashima Y; Makino I
Atherosclerosis; 1990 Sep; 84(1):49-53. PubMed ID: 2248620
[TBL] [Abstract][Full Text] [Related]
19. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
20. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study.
Schaefer EJ; Lamon-Fava S; Johnson S; Ordovas JM; Schaefer MM; Castelli WP; Wilson PW
Arterioscler Thromb; 1994 Jul; 14(7):1105-13. PubMed ID: 8018666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
